Evidence map›Paper›PMID 42577983›Full record

ArticleCureus2026

Rhinophyma: A Report of Two Patients Managed With Electrosurgery.

Houda El Abbade, Hanane Baybay, Riham Alheyasat, Sara Elloudi, FatimaZahra Mernissi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Houda El AbbadeDermatology, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, MAR.
Hanane BaybayDermatology, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, MAR.
Riham AlheyasatDermatology, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, MAR.
Sara ElloudiDermatology, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, MAR.
FatimaZahra MernissiDermatology, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rhinophyma is a chronic cutaneous condition secondary to rosacea that primarily affects the nose, leading to a bulbous and enlarged appearance. We report two cases of rhinophyma in 65- and 76-year-old men with long-standing rosacea evolving for more than 10 years. Both patients presented with progressive nasal enlargement, erythema, and nodular hypertrophy that had worsened over the previous five to seven years, leading to significant cosmetic and psychosocial impairment. The diagnosis was clinical. Surgical treatment was performed in both cases, including electrosurgical excision in one patient, allowing effective removal of hypertrophic tissue with good hemostasis and nasal remodeling. Postoperative care combined light-emitting diode photobiomodulation with adapted wound dressings and topical healing agents according to the stages of wound healing. Outcomes were favorable, with marked aesthetic improvement, reduction of nasal hypertrophy, and improved quality of life in both patients. Rhinophyma may significantly impair quality of life because of its progressive and disfiguring nature. Early management of rosacea with appropriate medical treatment is essential to limit progression; however, advanced hypertrophic forms may require therapeutic escalation to surgical approaches such as electrosurgery. In such cases, electrosurgical remodeling associated with appropriate postoperative wound care can provide favorable functional and aesthetic outcomes.

Indexed as

aesthetic outcomesdeformityelectrosurgerynasalrhinophymasebaceous glands

Identifiers

PMID42577983
PMCPMC13456070

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.